RESPONSIBLE PROVIDER IN ACCORDANCE WITH § 5 OF THE GERMAN TELEMEDIA ACT (TMG)

MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Telephone: +49 89 899 27-0
Fax: +49 89 899 27-222
Email: info@morphosys.com

 

RESPONSIBLE IN ACCORDANCE WITH § 18 PARA 2 OF THE GERMAN INTERSTATE TREATY ON BROADCASTING [MEDIENSTAATSVERTRAG – MSTV]

Charlotte Lohmann (Chief Legal Officer)
MorphoSys AG

 

MANAGEMENT BOARD

Jean-Paul Kress, M.D. (Chairman, CEO) and Lucinda Crabtree, Ph.D. (CFO)

 

CHAIRMAN OF THE SUPERVISORY BOARD 

Marc Cluzel, M.D., Ph.D.

 

COMMERCIAL REGISTER

District Court of Munich, HRB 121023

 

VAT ID NO.

DE 155069821

 

REGULATORY AUTHORITY 

Government of Upper Bavaria 

 

REGISTERED TRADEMARKS 

HuCAL^®, HuCAL GOLD^®, HuCAL PLATINUM^®, Ylanthia^®, 100 billion high potentials^®, Monjuvi^® and Minjuvi^® are trademarks of the MorphoSys Group. Tremfya^® is a trademark of Janssen Biotech, Inc. XmAb^® is a trademark of Xencor, Inc.

 

DESIGN & PROGRAMMING

Digitas Pixelpark
www.digitaspixelpark.com

 

For better understandability, the use of male and female language forms is avoided. All personal descriptions apply equally to all genders.